Yes, Fidelity Contrafund established a new position in Lam Research (LRCX) during Q3, purchasing approximately 1.13 million shares.
The acquisition was part of the fund's active management strategy to invest in companies with strong competitive positions and growth potential. The specific details of the transaction can be found in the fund's Q3 2024 holdings reports and SEC filings, which are publicly available on the official SEC website and Fidelity's fund research page.
https://fundresearch.fidelity.com/mutual-funds/view-all/316071109
No comments:
Post a Comment